Cytek Biosciences, Inc. 8-K

What Happened
Cytek Biosciences, Inc. (CTKB) filed an 8-K (Item 5.02) on June 2, 2026 announcing that Philippe Busque, Ph.D., submitted his resignation as Senior Vice President, Global Sales and Services. The resignation is effective June 5, 2026. The filing states Dr. Busque is leaving to pursue another career opportunity and that his departure is not due to any disagreement with the Company’s operations, policies or practices.

Key Details

• Filing: Form 8-K filed June 2, 2026 (Item 5.02).
• Executive: Philippe Busque, Ph.D., Senior Vice President, Global Sales and Services.
• Effective date: Resignation effective as of June 5, 2026.
• Reason: Departing to pursue another career opportunity; explicitly not due to any disagreement with Company operations, policies or practices.

Why It Matters
This is an executive leadership change in Cytek’s global sales organization. For investors, the items to watch next are any company announcements about an interim or permanent replacement and whether the change prompts updates to sales strategy or guidance. The company’s disclosure indicates the departure is voluntary and not related to internal disputes.